MACCS CVTeam: The Late Breakers - What You Must Know From ACC.26

Get up to speed on the top late breaking clinical trials that were presented in New Orleans at ACC.26.  Grab your cup of coffee, log on and quickly understand what your patients are going to be asking about and how it applies to your practice.

Target Audience

This activity is intended for an audience of pharmacists, nurses, nurse practitioners, and physician associates.

Learning Objectives

  • Evaluate emerging clinical trial data impacting cardiovascular practice. 
  • Compare novel pharmacologic and interventional therapies across cardiovascular conditions. 
  • Apply evidence-based strategies to improve patient outcomes in atrial fibrillation, pulmonary hypertension, heart failure, and coronary artery disease. 
  • Integrate new therapies into clinical decision-making while assessing safety and efficacy.
Course summary
Available credit: 
  • 2.00 AANP
  • 2.00 AAPA Category 1 CME
  • 2.00 ACPE Pharmacist
  • 2.00 ANCC

     

     

     

  • 2.00 Attendance
Course opens: 
04/18/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
April 18, 2026 - Virtual Event
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Dorothy Duffy, RPh

has no relevant financial relationships to disclose at this time.

Bernadette Maker, MSN, APRN-BC, NP-C

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Gayley Blaine, MSN, CRNP

has no relevant financial relationships to disclose at this time.

Steven Dunn

has no relevant financial relationships to disclose at this time.

Jennifer Fox

has no relevant financial relationships to disclose at this time.

Genise Green, ACNP-BC, CRNP

has a financial relationship (Advisor) with Bristol Myers Squibb;.
has a financial relationship (Advisor) with Alnylam;.

Robert Hipp, MS, MBA, PA-C

has a financial relationship (Advisor) with Medtronic;.

Maureen Julien, MSN, CRNP

has no relevant financial relationships to disclose at this time.

Jennifer Kliner

has no relevant financial relationships to disclose at this time.

Elizabeth Luttner, PA-C

has no relevant financial relationships to disclose at this time.

Maria Molina, DNP, AGACNP-BC, FAANP

has no relevant financial relationships to disclose at this time.

Amber Valimont, CRNP

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Pennsylvania Chapter, American College of Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.0 contact hours.

 

Nursing
Credit being awarded: 2.0 ANCC contact hours

 

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

 

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Pennsylvania Chapter, American College of Cardiology.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.0 contact hour(s) (which includes 1.5 hour(s) of pharmacology).

Available Credit

  • 2.00 AANP
  • 2.00 AAPA Category 1 CME
  • 2.00 ACPE Pharmacist
  • 2.00 ANCC

     

     

     

  • 2.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.